Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients
NCT06819449
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Leprosy
Mycobacterium Leprae Infection
Interventions
DRUG:
Dapsone
Sponsor
South Valley University